Tatton Consulting supported Birmingham-based epigenetics and biomarker discovery company Tagomics in its successful application to Innovation to Commercialisation of University Research (ICURe) follow on funding: FY20 round 1, awarded £299,213 by Innovate UK for the project Tagomics LTD.
About the funded R&D project
Global cancer cases are projected to reach 21.6 million by 2030. This ICURe-route award supported commercialisation of university research into Tagomics’ multiomics platform, which enriches unmethylated DNA for analysis without altering the underlying sequence.
Award details
- Grant awarded: £299,213
- Competition: Innovation to Commercialisation of University Research (ICURe) follow on funding: FY20 round 1
- Competition year: 2020/21
- Project: Tagomics LTD
- Sector: Cancer diagnostics / epigenetics
- UKRI project record: Gateway to Research, project 83244
- Dataset: Innovate UK funded projects, published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title are taken from UKRI’s published record for this project.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
